Keytruda showed a significant survival benefit over Tecentriq and Opdivo in older adults with metastatic NSCLC, with a 33% ...
The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...
The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM ESTCompany ParticipantsPeter Dannenbaum - Vice ...
Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...
Featured Top Story Editor's Pick Spotlight Family, friends, faith help longtime Orangeburg senator through cancer journey DIONNE GLEATON May 8, 2025 3 Beginning of dialog window. Escape will cancel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results